- Advertisement -
Melbourne-based respiratory imaging company 4DMedical (ASX: 4DX) has struck a deal with pharmaceutical giant GlaxoSmithKline to supply its proprietary quantitative lung imaging analytics in support of pulmonary drug development and clinical research.
The one-year contract, which kicks off next…
Click here to view the original article.
